Quick links


Whitepaper

The Blue Ocean Strategy in the Pharmaceutical Industry: What Is the Blue Ocean Strategy About?

Blue ocean refers to a new market that presents low competition, is less crowded, and is open to accommodate new innovations and marketing opportunities. Today the Pharma industry has a lot of blue ocean opportunities that are yet to be explored when it comes to digital innovations.

Key Takeaways:

  • SGA has helped design these blue ocean strategies for the client, enabling them to switch from red ocean to blue ocean.
  • It is a patient-centric data-gathering process designed for a specific disease. 
  • Through the process, we assisted the client in gathering significant insights from data streams, thus making it easier to present matches between patients with specific needs and identify the best therapies.

To know more...


Related Topics

SGA - M&E - Whitepaper - FAST Accelerator

White Papers

FAST Accelerator in Today’s Hybrid Monetization Era

Unified PaaS is set to become the new norm to help improve margins and reduce the total cost of ownership (TCO). FAST (free ad-supported streaming TV)...

SG Analytics Whitepaper B2B Payments

White Papers

B2B Payments: Is Cash Still a King or Now is the Time for...

The global B2B payments industry seems to be highly fragmented, with a lack of clear vendors holding the lion’s share in the market. The advent of new...

SG Analytics Whitepaper Reusable Data Products and Patterns Can Unlock New Opportunities

White Papers

Reusable Data Products and Patterns Can Unlock New...

Despite recognizing the power of data, and the likelihood of the emergence of smart workflows and seamless communications between humans and machines in the...

VIEW MORE

We bring comprehensive data driven insights to everyone, everywhere